Clinical Trials Browser

Phase 3 × OTHER × CEOP protocol 1 × Clear all

NCT00854568 2014-08-20

Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL

Phase 3 Completed

Lymphoma, Lymphoma, B-Cell, Cardiotoxicity